188 related articles for article (PubMed ID: 12410583)
21. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
[TBL] [Abstract][Full Text] [Related]
22. Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Sekhri A; Liu D; Rasul M; Ahmed N; Ahmed T; Seiter K
Leuk Res; 2009 Sep; 33(9):1291-3. PubMed ID: 19344950
[TBL] [Abstract][Full Text] [Related]
23. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
24. Bedside story.
Camb Q Healthc Ethics; 1992; 1(4):409-10. PubMed ID: 1342363
[TBL] [Abstract][Full Text] [Related]
25. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.
Bielorai B; Deeg HJ; Weintraub M; Neumann Y; Rosner E; Amariglio N; Rechavi G; Toren A
Bone Marrow Transplant; 2003 May; 31(10):931-4. PubMed ID: 12748672
[TBL] [Abstract][Full Text] [Related]
26. A gift of life--bone marrow transplant.
Albert E; Silkworth C
Nasnewsletter; 1991 May; 6(3):9. PubMed ID: 2031165
[No Abstract] [Full Text] [Related]
27. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
[TBL] [Abstract][Full Text] [Related]
28. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
29. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors.
Sedlacek P; Formankova R; Mejstrikova E; Keslova P; Hubacek P; Dobrovolna M; Vrana M; Kupkova L; Pittrova H; Stary J
Pediatr Transplant; 2008 Feb; 12(1):24-31. PubMed ID: 18186885
[TBL] [Abstract][Full Text] [Related]
31. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
[TBL] [Abstract][Full Text] [Related]
32. Predicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1993; 12 Suppl 1():82-3. PubMed ID: 8374572
[No Abstract] [Full Text] [Related]
33. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplant relapse with loss of an allele.
Chen DP; Tsai SH; Tseng CP; Wu TL; Chang PY; Sun CF
Clin Chim Acta; 2008 Jan; 387(1-2):161-4. PubMed ID: 17916344
[TBL] [Abstract][Full Text] [Related]
35. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
36. Chronic myelogenous leukemia.
Swabb RJ
Alaska Med; 1991; 33(2):99. PubMed ID: 1892236
[No Abstract] [Full Text] [Related]
37. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous occurrence of multiple myeloma and chronic myeloid leukemia.
Alvarez-Larrán A; Rozman M; Cervantes F
Haematologica; 2001 Aug; 86(8):894. PubMed ID: 11524262
[No Abstract] [Full Text] [Related]
39. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
[TBL] [Abstract][Full Text] [Related]
40. [Recent progress in hematopoietic stem cell transplantation].
Shinagawa K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):727-35. PubMed ID: 16770089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]